Insight Provider, CrossASEAN Research

Nicolas Van Broekhoven

Insight Provider

CrossASEAN Research

At CrossASEAN Research we strive to produce unbiased and differentiated on the ground insights on companies across South East Asia. Our Research is produced for the most part after face to face meetings and conversations with company management to dig deep into the long term vision and strategy of the companies we cover. We seek to deliver investable and actionable themes on sectors and markets across SE Asia, often in collaboration with other Insight Providers across the region, pooling the vast experience of the analysts within the Smartkarma Ecosystem. We also offer bespoke work and tailor made trips for our clients. 

Insights across South East Asia

Equity Bottom-Up

<a href="https://www.smartkarma.com/entities/olam-international-ltd" target="_blank" data-smartkarma-citation="entities:765:1" rel="noopener">Olam International (OLAM SP)</a> has been a poor stock price performer on the SGX ever since it was attacked by short-seller Muddy Waters in 2012. Olam was essentially rescued by Temasek while peer Noble went bust. The 10-year stock chart says it all. Olam recently closed at 1.76 SGD, far below its peak of 2.64 SGD last reached in February 2012!<figure class="editor-figure mceNonEditable"><img src="https://static-prod.smartkarma.com/images/media/000/233/967/original/image_58873528221633585900666.png?1633585903" class="editor-image img-responsive" data-smartkarma-image-id="233967"></figure>Fast forward almost ten years and Olam is set to go into a period of heightened corporate activity to get Temasek (53% shareholder) its required exit. As well-telegraphed OFI (Olam Food Ingredients) will list on the LSE in 1H22. The OGA (Olam Global Agri) business could get a listing in the US by late 2022 or early 2023.Both listings could unlock significant value for Temasek and Olam minorities. We expect full-on press coverage, analyst, and corporate banking awareness of the OFI deal come 1H22. Olam is a small company in a global context but at 6.7 billion SGD (18 billion SGD Enterprise Value) it is a big deal for the SGX.Back-of-the-envelope calculations and comments to Reuters and The Times make us conclude that Olam could be worth well over 3 SGD/share depending on the eventual OFI valuation and debt assigned to the unit. In a blue-sky scenario, we even get a valuation as high as 4 SGD. That is 70% to 124% upside from Olam's last traded price on SGX. In this scenario, we assign 0 value to OGA which is unrealistic. Major wild card: what % of Olam's 15 billion SGD debt gets assigned to OFI.Given Temasek's ($400 billion AUM and Singapore's key SWF) importance to global investment banks, we are betting that the players involved will pull out all stops to make OFI's listing a success. Minority investors looking to ride the coattails of "the great Temasek unlock" would be wise to position themselves in Olam stock during 4Q21. The downside is protected by a 4% dividend yield which should be safe in case capital markets make an IPO impossible in 1H22.

Olam International (OLAM SP) has been a poor stock price performer on the SGX ever since it was attacked by short-seller Muddy Waters in 2012. Olam was essentially rescued by Temasek while peer Noble went bust. The 10-year stock chart says it all. Olam recently closed at 1.76 SGD, far below its peak of 2.64 SGD last reached in February 2012!Fast forward almost ten years and Olam is set to go into a period of heightened corporate activity to get Temasek (53% shareholder) its required exit. As well-telegraphed OFI (Olam Food Ingredients) will list on the LSE in 1H22. The OGA (Olam Global Agri) business could get a listing in the US by late 2022 or early 2023.Both listings could unlock significant value for Temasek and Olam minorities. We expect full-on press coverage, analyst, and corporate banking awareness of the OFI deal come 1H22. Olam is a small company in a global context but at 6.7 billion SGD (18 billion SGD Enterprise Value) it is a big deal for the SGX.Back-of-the-envelope calculations and comments to Reuters and The Times make us conclude that Olam could be worth well over 3 SGD/share depending on the eventual OFI valuation and debt assigned to the unit. In a blue-sky scenario, we even get a valuation as high as 4 SGD. That is 70% to 124% upside from Olam's last traded price on SGX. In this scenario, we assign 0 value to OGA which is unrealistic. Major wild card: what % of Olam's 15 billion SGD debt gets assigned to OFI.Given Temasek's ($400 billion AUM and Singapore's key SWF) importance to global investment banks, we are betting that the players involved will pull out all stops to make OFI's listing a success. Minority investors looking to ride the coattails of "the great Temasek unlock" would be wise to position themselves in Olam stock during 4Q21. The downside is protected by a 4% dividend yield which should be safe in case capital markets make an IPO impossible in 1H22.

Olam: Lots of Corporate Activity in '22/'23 to Unlock Significant Value for Temasek and Minorities

Energy Transition | AI | Shifting World Order, Mint Finance

Srinidhi Raghavendra

Energy Transition | AI | Shifting World Order

Deep Fundamental Analysis

Mint Finance

Mint Finance's investment research blends deep fundamental analysis with technical & quant insights. Investment strategies straddle across multiple asset classes with risk management embedded into every trade to deliver an outsized reward-to-risk ratio.

Mint Finance's research is centered around three key themes. First, energy transition and climate change. Second, artificial intelligence. Third, shifting world order with its impact across politics and monetary economics.

Cross Asset Strategy

<ul>
<li>Markets raced to 52-week highs across US equity benchmarks with rally in tech stocks contributing to much of these gains. Nikkei raced to print another 34-year high.</li>
<li>Oil &amp; Copper ticked higher while other major commodities trended downwards last week. Beans and Corn marked their lowest price prints over the last 52-weeks.</li>
<li>Life is too short to be spent writing for an echo chamber and rewriting to meet the often arbitrary demands of a reviewer, writes Dr Damodaran.</li>
</ul>


Markets raced to 52-week highs across US equity benchmarks with rally in tech stocks contributing to much of these gains. Nikkei raced to print another 34-year high.
Oil &amp; Copper ticked higher while other major commodities trended downwards last week. Beans and Corn marked their lowest price prints over the last 52-weeks.
Life is too short to be spent writing for an echo chamber and rewriting to meet the often arbitrary demands of a reviewer, writes Dr Damodaran.


[TW2] US & JPN Equities on Steroids While China Remains Shaky on Deflation Fears (W/E 19th Jan 24)

Pan-Asia Catalysts/Events, Quiddity Advisors

David Blennerhassett

Pan-Asia Catalysts/Events

Quiddity Advisors

Event-Driven

<ul>
<li>
<a href="https://www.smartkarma.com/entities/furuya-metal-co-ltd" target="_blank" data-smartkarma-citation="entities:5196:1" rel="noopener">Furuya Metal (7826 JP)</a> and <a href="https://www.smartkarma.com/entities/visional-inc" target="_blank" data-smartkarma-citation="entities:32977:1" rel="noopener">Visional (4194 JP)</a> are expected to be included in the TOPIX index at the end of January 2024. </li>
<li>
<a href="https://www.smartkarma.com/entities/wilmar-international-ltd" target="_blank" data-smartkarma-citation="entities:172:1" rel="noopener">Wilmar International (WIL SP)</a>'s current implied stub and simple ratio (Wilmar/ <a href="https://www.smartkarma.com/entities/yihai-kerry-arawana-holdings-c" target="_blank" data-smartkarma-citation="entities:33230:1" rel="noopener">Yihai Kerry Arawana Holdings (300999 CH)</a>) are both at all-time highs.</li>
<li>Reportedly, the mother and two sisters of <a href="https://www.smartkarma.com/entities/samsung-electronics-co-ltd" target="_blank" data-smartkarma-citation="entities:191:1" rel="noopener">Samsung Electronics (005930 KS)</a> Chairman Jay Y. Lee plan to sell shares in a block deal worth ~₩2.8tn ($2.1bn billion.</li>
</ul>



Furuya Metal (7826 JP) and Visional (4194 JP) are expected to be included in the TOPIX index at the end of January 2024. 

Wilmar International (WIL SP)'s current implied stub and simple ratio (Wilmar/ Yihai Kerry Arawana Holdings (300999 CH)) are both at all-time highs.
Reportedly, the mother and two sisters of Samsung Electronics (005930 KS) Chairman Jay Y. Lee plan to sell shares in a block deal worth ~₩2.8tn ($2.1bn billion.


Last Week in Event SPACE: Furuya Metal, Visional, Wilmar, Samsung Electronics, ViinFast/Vingroup

<ul>
<li>
<a href="https://www.smartkarma.com/entities/wilmar-international-ltd" target="_blank" data-smartkarma-citation="entities:172:1" rel="noopener">Wilmar International (WIL SP)</a>'s current implied stub and simple ratio (Wilmar/<a href="https://www.smartkarma.com/entities/yihai-kerry-arawana-holdings-c" target="_blank" data-smartkarma-citation="entities:33230:1" rel="noopener">Yihai Kerry Arawana Holdings C (300999 CH)</a>) are both at all-time highs. </li>
<li>Preceding my comments on Wilmar are the current setup/unwind tables for Asia-Pacific Holdcos.</li>
<li>These relationships trade with a minimum liquidity of US$1mn, and a % market capitalisation &gt;20%.</li>
</ul>



Wilmar International (WIL SP)'s current implied stub and simple ratio (Wilmar/Yihai Kerry Arawana Holdings C (300999 CH)) are both at all-time highs. 
Preceding my comments on Wilmar are the current setup/unwind tables for Asia-Pacific Holdcos.
These relationships trade with a minimum liquidity of US$1mn, and a % market capitalisation &gt;20%.


StubWorld: Wilmar's All-Time High Implied Stub As Yihai Kerry Touches New Lows

Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Capital Markets

Archer Daniels Midland Co / Equity Capital Markets

<ul><li>Archer-Daniels-Midland had a mixed first quarter as the company failed to meet the revenue expectations of Wall Street despite delivering healthy earnings and cash flows.</li><li>ADM's portfolio and integrated value chain enabled them to respond promptly to emerging opportunities in line with the enduring trends of food security, health and well-being, and sustainability.</li><li>In this report, we have carried out a fundamental analysis of the historical financial statements of the company.</li></ul>

Archer-Daniels-Midland had a mixed first quarter as the company failed to meet the revenue expectations of Wall Street despite delivering healthy earnings and cash flows.ADM's portfolio and integrated value chain enabled them to respond promptly to emerging opportunities in line with the enduring trends of food security, health and well-being, and sustainability.In this report, we have carried out a fundamental analysis of the historical financial statements of the company.

Archer-Daniels-Midland Company: Expansion of Cultivated Meat Industry & Other Drivers

United States

Archer-Daniels-Midland Company procures, transports, stores, processes, and merchandises agricultural commodities and products. The Company processes oilseeds, corn, milo, oats, barley, peanuts, and wheat. Archer-Daniels-Midland also processes produce products which have primarily two end uses including food or feed ingredients.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Archer Daniels Midland Co (ADM US)

Olam: Lots of Corporate Activity in '22/'23 to Unlock Significant Value for Temasek and Minorities

Olam is set to see a significant increase in corporate activity in 1H22. Investors would be wise to position in the stock before the newsflow hits...

Nicolas Van Broekhoven

[TW2] US & JPN Equities on Steroids While China Remains Shaky on Deflation Fears (W/E 19th Jan 24)

Animal spirits were back in charge last week as market sentiments rose high. US and Japanese equity markets continue to set record highs. Are we...

Mint Finance

Last Week in Event SPACE: Furuya Metal, Visional, Wilmar, Samsung Electronics, ViinFast/Vingroup

The weekend is here! Pour yourself a coffee, grab a comfortable seat, and sift through a brief summary of insights on various events discussed...

David Blennerhassett

StubWorld: Wilmar's All-Time High Implied Stub As Yihai Kerry Touches New Lows

I'd be reluctant to short Wilmar, long YKA here. I might look to short Wilmar against a basket of larger peers (ADM, Bunge etc). I would not be...

David Blennerhassett

Archer-Daniels-Midland Company: Expansion of Cultivated Meat Industry & Other Drivers

Archer-Daniels-Midland had a mixed first quarter as the company failed to meet the revenue expectations of Wall Street despite delivering healthy...

Baptista Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)